Approval · Notice of Compliance 2718 · 1998
CYSTADANE: Notice of Compliance 2718
Issued July 30, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2718
- Date
- July 30, 1998
- Company
- Orphan Medical Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Anti-homocysteine agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSTADANE | 02238526 | Marketed |
Medicinal ingredients
- BETAINE 1 G per UNIT